Relationship between Red Cell Distribution width and Stroke in Patients with Stable Chronic Heart Failure: A Propensity Score Matching Analysis  by Kaya, Ahmet et al.
O
R
A
L
S0.98 p<0.0001), hs-CRP (AUC 0.958 p<0.0001) and uric acid (AUC 0.97 p<0.0001)
with ROC curve analysis in patients with CHF (Figure).
Conclusion: We identiﬁed 29 miRNAs that were elevated in patients with CHF,
among which miR-4278, miR-516-a-5p and miR-1228 were most signiﬁcant in terms
of clinical diagnosis. This study demonstrates the value of miR-4278, miR-516-a-5p,
miR-1228 as potential diagnostic biomarkers in CHF.OP-044
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Purpose: Heart Failure (HF) is a fatal disease. Several biomarkers are of interest with
regard to prognosis. However, plasma osmolality which unites the individual inﬂu-
ences of sodium, BUN and glucose has not been studied.
Methods: 496 patients with HF out of two participating centers were investigated as
part of a larger cohort and followed up to 111 months. Plasma osmolality was
calculated as "(2*Na)+(BUN/2.8)+(Glucose/18)". When ROC curve was obtained, it
was noticed that the curve is sigmoid shaped. Hence three subcategories were iden-
tiﬁed. Patients were classiﬁed into three groups as follows: Those with plasma
osmolality<287 mOsm/kg (hypoosmolality), those with osmolality between 287-295
(normoosmolality, blue line in ﬁgure), and those with plasma osmolality>295 mOsm/
kg (hyperosmolality).
Results: Mean EF of the cohort was 2710% with a mean age of 55.917.8 years
(369 males, 127 females) Patients were followed up for 2723 months and mortality
was noted. Kaplan Meier curves for three subcategories of plasma osmolality sepa-
rated from each other (p¼0.0296, Figure 1). After follow up, 42.6% of those with low
osmolality, 34.7% of those with high osmolality versus 22.8% of those with
normoosmolality died (p¼0.0003). It was also noted that up to 40 months of follow
up, those with hypoosmolality (red line) had the worst prognosis, then, there was
a switch between hypo and hyperosmolality groups with the hyperosmolality group
(yellow line) having the worst prognosis thereafter.
Conclusion: Plasma osmolality predicts both mid term and long term mortality of
patients.C18 JACC VOP-045
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Aim: Although it was shown that increased basal red cell distribution width (RDW)
level is an index of hospitalization and mortality of patient with heart failure (HF),
the relationship between RDW and risk of stroke has not been investigated
comprehensively Therefore, in this particular study, we aimed to investigate the
association between baseline RDW level and the risk of stroke in heart failure patients.
Methods: One hundred-ﬁfty three consecutive HF patients [NYHA I–III and left
ventricular ejection fraction (LVEF) of <40%] were included in this prospective
study. All patients were followed up for one year and during this period cerebro-
vascular disease was questioned.
Results: In matched population, using propensity score matching, HF patients
suffering from stroke compared with patients without stroke we found signiﬁcantly
increased basal RDW and serum uric acid. The ROC curves of RDW for predicting
stroke is shown that RDW 15.2% measured on admission had 87% sensitivity and
74% speciﬁcity in predicting stroke in patients with heart failure (AUC:0.923, 95%
CI: 0.852-0.994, p<0.001).
Conclusion: In this study, for the ﬁrst time in literature, we evaluated the relationship
between baseline RDW levels and the risk of stroke in heart failure patients. The study
results revealed that elevated basal levels of RDW in stable heart failure patients are
signiﬁcantly associated with stroke, according to propensity score analysis.
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Purpose: The purpose of investigation to study relation to levels of erythropoietin and
pathological cytokine of patients in chronic heart failure with anaemic syndrome and
erythropoietinic effect and security of continuous erythropoietin receptor activator
methoxy polyethilenglicol-epoietin beta (MEB) its impact on this relation and on
regress of symptoms chronic heart failure.
Methods: 94 patients with chronic heart failure of New York Heart Association
(NYHA) class ___-_V a left ventricular ejection fraction of 40% or less with anaemia
were included in investigation. Mean age of patients 59,71,6 years (58 males,
36 females). A hemoglobin level of less 120 g/l by males and less 110g/l by females.
46 patients were treated basis treatment of CHF (_ group) and 48 patients were
treated with MEB (__ group). Percutaneous MEB in dose 50 IU in day in one months
patients without iron deﬁciency to receive in follow-up on 6 months. Echocardio-
graphic indices of LV systolic and diastolic function, plasma NT pro BNP, cytocine,
erythropoietin, ferritin and 6 minute walked distance were assessed at baseline and
posttreatment.
Results: On the patients CHF with anemic syndrome in __ group MEB treatment the
level Hb increased on 22,4% (p<0,05) and erythropoietin levels in serum plasma
increased to 29,34,3 IU/ml (p<0,001).The increase the level of erythropoietin
connected with the decrease of level pathological cytokines: Il-1on 36,6% (p<0,001),
Il-6 on 54,3% (p<0,05),TNF-a on 48,3% (p<0,05) compared with of patients
receiving _ group. MEB treatment had a signiﬁcantly increase LVEF on 19,04%
(p<0,05) as compared with of patients receiving _ group.A greater 6-minute distance
walked on exercise testing increased on 76,6% (p<0,05) after treatment MEB.There
was also a signiﬁcant fall in serum NT pro BNP levels from 387,452,3 fmol/ml to
198,130,3 fmol/ml (p<0,01).
Conclusion: On the patients of CHF with anemic syndrome erythropoietin failure
increase sytokincal aggression with worsens clinical picture of the illness. Correction
of anemic syndrome with application of percutaneus ME B in dose 50 IU in day in one
month in follow-up 6 months effective to improve erythropoietin failure and cytokinic
aggression connected to it and anemia; clinical symptoms and quality of life in
anaemic CHF patients.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
